MZE782

N/A

Report date: 2024/10/11 15:34:48
NME

Base Information

Drug NameMZE782
Drug Alias NameMZE-782MZE782
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium-dependent neutral amino acid transporter B(0)AT1 inhibitors
TargetsSodium-dependent neutral amino acid transporter B(0)AT1
Therapy Area/IndicationsRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMaze Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMaze Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A